Rituximab, cladribine, and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG - CLL4 (ML21283) trial-Reference-Cited by-同舟云学术

Rituximab, cladribine, and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG - CLL4 (ML21283) trial

Published:2018-03-22 Issue:5 Volume:100 Page:465-474
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Robak Tadeusz¹^ORCID,Błoński Jerzy¹,Skotnicki Aleksander Bartłomiej²,Piotrowska Magdalena²,Wróbel Tomasz³,Rybka Justyna³,Kłoczko Janusz⁴,Bołkun Łukasz⁴,Budziszewska Bożena Katarzyna⁵,Walczak Urszula⁵,Uss Anatoly⁶,Fidecka Marta⁷,Smolewski Piotr⁸

Affiliation:

1. Department of Hematology; Copernicus Memorial Hospital; Medical University of Lodz; Lodz Poland

2. Department of Hematology; Jagiellonian University; Kraków Poland

3. Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation; Wroclaw Medical University; Wroclaw Poland

4. Department of Hematology; Medical University of Białystok; Białystok Poland

5. Department of Hematology; Institute of Hematology and Transfusion Medicine; Warsaw Poland

6. City Clinical Hospital No. 9; Minsk Belarus

7. Roche Poland; Warsaw Poland

8. Department of Experimental Hematology; Copernicus Memorial Hospital; Medical University of Lodz; Lodz Poland

Funder

Roche

Uniwersytet Medyczny w Lodzi

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13042/fullpdf

Reference32 articles.

1. 2016 US lymphoid malignancy statistics by World Health Organization subtypes;Teras;CA Cancer J Clin,2016

2. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Eichhorst;Ann Oncol,2015

3. How I treat CLL up front;Gribben;Blood,2010

4. Front-line treatment of CLL in the era of novel agents;Robak;Cancer Treat Rev,2017

5. Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients;Leporrier;Blood,2001

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance therapy for chronic lymphocytic leukaemia;Cochrane Database of Systematic Reviews;2024-01-04

2. Prognostic markers in patients with chronic lymphocytic leukaemia on targeted therapy, chemoimmunotherapy with anti-CD20 monoclonal antibody: a systematic review and meta-analysis of prognostic factors;BMC Cancer;2022-11-25

3. The influence of venetoclax, used alone or in combination with cladribine (2-CdA), on CLL cells apoptosis in vitro: Preliminary results;Advances in Clinical and Experimental Medicine;2022-04-25

4. Effects of rituximab therapy on B cell differentiation and depletion;Clinical Rheumatology;2020-02-22

5. A network meta-analysis of maintenance therapy in chronic lymphocytic leukemia;PLOS ONE;2020-01-29